-
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3132)
All Articles published online
|
Publishing Process of This Article
|
Apr 15, 2021 (publication date) through May 31, 2023
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xiao L, Sun L, Zhao K, Pan YS. Crohn’s disease with infliximab treatment complicated by rapidly progressing colorectal cancer: A case report. World J Gastrointest Oncol 2021; 13(4): 305-311 [PMID: 33889281 DOI: 10.4251/wjgo.v13.i4.305] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v13/i4/305.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Shruthi Karthikeyan, Jeanne Shen, Kian Keyashian, John Gubatan. Small bowel adenocarcinoma in neoterminal ileum in setting of stricturing Crohn’s disease: A case report and review of literature . World Journal of Clinical Cases 2023; 11(9): 2021-2028 doi: 10.12998/wjcc.v11.i9.2021
Abstract(85) |
Core Tip(79) |
Full Article(HTML)(375)
|
Full Article (PDF)-4000K(43)
|
Full Article (Word)-3403K(11)
|
Audio-722K(0)
|
Peer-Review Report-533K(5)
|
Answering Reviewers-141K(10)
|
Times Cited (0)
|
Total Visits (1135)
|
Open
|
| 3 |
Yoshiki Morihisa, Shunji Urai, Hiroyoshi Iwagami, Masayuki Shimoyama, Shinya Ogino, Tomoko Terashita, Hiroki Morimura, Takuji Akamatsu, Yoshito Uenoyama, Yukitaka Yamashita. A Case of Primary Retroperitoneal Mucinous Cystadenocarcinoma during Long-term Administration of Infliximab for the Treatment of Crohn's Disease. Internal Medicine 2023; doi: 10.2169/internalmedicine.1593-23
|